Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ciatto C, Bahna F, Zampieri N, VanSteenhouse HC, Katsamba PS, Ahlsen G et al (2010). T-cadherin structures reveal a novel adhesive binding mechanism. Nat Struct Mol Biol 17: 339–347.
Ishiguro H, Liu QR, Gong JP, Hall FS, Ujike H, Morales M et al (2006). NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology 31: 572–584.
Li CY, Liu QR, Zhang PW, Li XM, Wei L, Uhl GR (2009). OKCAM: an ontology-based, human-centered knowledgebase for cell adhesion molecules. Nucleic Acids Res 37 (Database issue): D251–D260.
Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P et al (2008). PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 40: 946–948.
Uetani N, Chagnon MJ, Kennedy TE, Iwakura Y, Tremblay ML (2006). Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J Neurosci 26: 5872–5880.
Uhl GR, Drgon T, Johnson C, Li CY, Contoreggi C, Hess J et al (2008). Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify ‘connectivity constellation’ and drug target genes with pleiotropic effects. Ann N Y Acad Sci 1141: 318–381.
Acknowledgements
This study was supported by the National Institutes of Health (NIH)–Intramural Research Program, NIDA, DHHS (Dr Uhl).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uhl, G., Drgonova, J. Cell Adhesion Molecules: Druggable Targets for Modulating the Connectome and Brain Disorders?. Neuropsychopharmacol 39, 235 (2014). https://doi.org/10.1038/npp.2013.240
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2013.240